Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

On firm foundations.

Gavaghan H.

Nature. 2005 Aug 4;436(7051):748-9. No abstract available.

PMID:
16086447
2.

[The stem cell promise].

Gavaghan H.

Servir. 2002 Jan-Feb;50(1):31-4. Portuguese. No abstract available.

PMID:
12068655
3.

Lead, unsafe at any level.

Gavaghan H.

Bull World Health Organ. 2002;80(1):82. No abstract available.

4.

Life in the deep freeze.

Gavaghan H.

Nature. 2002 Feb 21;415(6874):828-30. No abstract available.

PMID:
11859334
5.

Researchers plan probe into Antarctic lakes.

Gavaghan H.

Nature. 2001 Dec 6;414(6864):573. No abstract available.

PMID:
11740519
6.

A grassroots revolution.

Gavaghan H.

Nature. 2001 Nov 8;414(6860):6-7. No abstract available.

PMID:
11700504
7.

The promise of stem cells.

Gavaghan H.

Bull World Health Organ. 2001;79(8):800-1. Epub 2001 Oct 24. No abstract available.

8.

Cassini-Huygens. Mission to Saturn rises from ashes.

Gavaghan H.

Science. 2001 Jul 13;293(5528):193. No abstract available.

PMID:
11452092
9.

Human genome sequences--a potential treasure trove, but how useful?

Gavaghan H.

Bull World Health Organ. 2001;79(6):583-4. No abstract available.

10.

Space research. ESA embraces astrobiology.

Gavaghan H.

Science. 2001 Jun 1;292(5522):1626-7. No abstract available.

PMID:
11387447
11.

Biology moves into the silicon stage.

Gavaghan H.

Nature. 2001 Feb 15;409(6822):964. No abstract available.

PMID:
11241987
12.

Tips for sequence centre job-seekers.

Gavaghan H.

Nature. 2001 Feb 15;409(6822):964. No abstract available.

PMID:
11241986
13.

Current role suggests the shape of future work opportunities.

Gavaghan H.

Nature. 2001 Feb 15;409(6822):963-4. No abstract available.

PMID:
11237023
14.

U.K. mad cow disease. Report flags hazards of risk assessment.

Gavaghan H.

Science. 2000 Nov 3;290(5493):911-3. No abstract available.

PMID:
11184726
15.

Governments prime basic nanotech research, applied activity yet to soar.

Gavaghan H.

Nature. 2000 Nov 30;408(6812):619-20. No abstract available.

PMID:
11117753
16.

Mergers and acquisitions rock UK chemical industry infrastructure.

Gavaghan H.

Nature. 2000 Aug 17;406(6797):812. No abstract available.

PMID:
10963615
17.

Emerging fields of basic chemistry in Europe.

Gavaghan H.

Nature. 2000 Aug 17;406(6797):811-2. No abstract available.

PMID:
10963614
18.

European industry turns to the academics to secure its future.

Gavaghan H.

Nature. 2000 Aug 17;406(6797):809-11. No abstract available.

PMID:
10963613
19.

New UK legislation aids fight against discrimination.

Gavaghan H.

Nature. 2000 Jun 8;405(6787):716-7. No abstract available.

PMID:
10864334
20.

Making moves to redress the gender imbalance.

Gavaghan H.

Nature. 2000 Jun 8;405(6787):715-6. No abstract available.

PMID:
10864333
21.

Europe seeks solution to bioinformatics shortfall.

Gavaghan H.

Nature. 2000 Apr 6;404(6778):687-8. No abstract available.

PMID:
10766258
22.

Companies of all sizes are prospecting for proteins.

Gavaghan H.

Nature. 2000 Apr 6;404(6778):684-6. No abstract available.

PMID:
10766256
23.

Wellcome seeks new home for business park.

Gavaghan H.

Science. 1999 Sep 17;285(5435):1830-1. No abstract available.

PMID:
10515784
24.

Genetically modified food. Britain struggles to turn anti-GM tide.

Gavaghan H.

Science. 1999 May 28;284(5419):1442-4. No abstract available.

PMID:
10383316
25.

UN to end Children's Vaccine Initiative.

Gavaghan H.

Science. 1999 Mar 26;283(5410):1992-3. No abstract available.

PMID:
10206898
26.

Taking knowledge from bench to bank.

Horton B, Wickware P, Gershon D, Gavaghan H.

Nature. 1998 Sep 24;395(6700):409-14. No abstract available.

PMID:
9759734
27.

Arms control enters the biology lab.

Gavaghan H.

Science. 1998 Jul 3;281(5373):29-30. No abstract available.

PMID:
9679013
28.

EU ends 10-year battle over biopatents.

Gavaghan H.

Science. 1998 May 22;280(5367):1188. No abstract available.

PMID:
9634397
29.

Largest-ever study contests radiation role in childhood cancers.

Gavaghan H.

Nature. 1997 Nov 13;390(6656):107. No abstract available.

PMID:
9367141
30.

Bioinformatics in a post-genomics age.

Gershon D, Sobral BW, Horton B, Wickware P, Gavaghan H, Strobl M.

Nature. 1997 Sep 25;389(6649):417-22. No abstract available.

PMID:
9324648
31.

NIH drops reasonable pricing clause.

Gavaghan H.

Nature. 1995 Apr 20;374(6524):669. No abstract available.

PMID:
7715715
32.

Congress turns spotlight on US drug approval agency.

Gavaghan H.

Nature. 1995 Apr 13;374(6523):582. No abstract available.

PMID:
7715685
33.

NIH wins patent on basic technique covering all ex vivo gene therapy.

Gavaghan H.

Nature. 1995 Mar 30;374(6521):393. No abstract available.

PMID:
7700334
34.

NIH to review priorities in readiness for future cuts...

Gavaghan H.

Nature. 1995 Mar 23;374(6520):294. No abstract available.

PMID:
7885453
35.

US sets up new bioethics advisory board.

Gavaghan H.

Nature. 1995 Mar 16;374(6519):202. No abstract available.

PMID:
7885433
36.

Gene therapy approval may be rocky road for industry.

Gavaghan H.

Nature. 1995 Mar 16;374(6519):202. No abstract available.

PMID:
7885431
37.

AIDS activists seek speedy access to protease drugs....

Gavaghan H.

Nature. 1995 Mar 2;374(6517):4. No abstract available.

PMID:
7870168
38.

NIH resolves dispute on cancer gene patent.

Gavaghan H.

Nature. 1995 Feb 23;373(6516):649. No abstract available.

PMID:
7854429
39.

Medical schools fight their corner.

Gavaghan H.

Nature. 1995 Feb 23;373(6516):649. No abstract available.

PMID:
7854427
40.

NIH: in line with expectations.

Gavaghan H.

Nature. 1995 Feb 9;373(6514):461. No abstract available.

PMID:
7845447
41.

AIDS activists fail to block 'reasonable pricing' reform.

Gavaghan H.

Nature. 1995 Jan 26;373(6512):272. No abstract available.

PMID:
7830751
42.

Clinical trials face lack of minority group volunteers.

Gavaghan H.

Nature. 1995 Jan 19;373(6511):178. No abstract available.

PMID:
7816116
43.

Embryo research tests NIH's mettle.

Gavaghan H.

Nat Med. 1995 Jan;1(1):5-6. No abstract available.

PMID:
11644731
44.

Fetal gene therapy under the microscope...

Gavaghan H.

Nature. 1994 Dec 8;372(6506):490. No abstract available.

PMID:
7990912
45.

As US bans 'embryos for research'.

Gavaghan H.

Nature. 1994 Dec 8;372(6506):490. No abstract available.

PMID:
7990911
46.

ORI finds Imanishi-Kari guilty of misconduct, proposes 10-year ban.

Gavaghan H.

Nature. 1994 Dec 1;372(6505):391. No abstract available.

PMID:
7984221
47.

NIH seeks bids for vector centres for gene therapy.

Gavaghan H.

Nature. 1994 Nov 24;372(6504):306. No abstract available.

PMID:
7969478
48.

Researchers face delay in supplies of RU486.

Gavaghan H.

Nature. 1994 Nov 17;372(6503):209. No abstract available.

PMID:
7969456
49.

Changes urged in NIH peer review process.

Gavaghan H.

Nature. 1994 Nov 17;372(6503):209. No abstract available.

PMID:
7969455
50.

Varmus speaks out on need to boost clinical research.

Gavaghan H.

Nature. 1994 Nov 10;372(6502):118. No abstract available.

PMID:
7969431

Supplemental Content

Loading ...
Support Center